This is based on real research from KAIST in South Korea. Their 2025 study in Advanced Science shows a molecular switch can revert colon cancer cells to a normal-like state in lab models. It’s promising but preclinical—no human treatments yet.

They blocked specific enzymes (like HDACs) that control gene expression. This triggered the cancer cells to stop multiplying and transform back into normal tissue cells. No chemotherapy. No radiation. Just biological reprogramming. A potential game-changer in cancer treatment.

This is a groundbreaking step not just in cancer treatment, but in how we understand cellular identity and plasticity. Reverting cancer cells to normal ones could shift the paradigm from destruction to restoration treating the disease not by killing cells, but by healing them. If this holds up through clinical stages, it’s the kind of innovation that could redefine modern medicine.

Exciting step forward!

HOW TO CONSULT WITH BWS?
Rates: $100 | 30 minute

Contact: TO PARTNER OR FOR CONSULTATION
Emeritus Prof Ifeoma Okoye

Email: sales@slaynetwork.co.uk

Website: https://slaylebrity.com/users/pinkyprof/
Instagram: @pinkyprof_wellness


DOWNLOAD THE BWS BROCHURE

REACH OUT TO US HERE

PS: If you will like to join Slaylebrity VIP social network pls contact sales@slaynetwork.co.uk and include referred by BWS in your subject cheers!

This is based on real research from KAIST in South Korea. Their 2025 study in Advanced Science shows a molecular switch can revert colon cancer cells to a normal-like state in lab models. It's promising but preclinical—no human treatments yet.

Leave a Reply